logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Xphyto Closes First Tranche Of Financing

Mar 31, 2022•over 3 years ago
Vancouver

Description

VANCOUVER, BC and UTTENWEILER, GERMANY / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that further to its news release of March 25, 2022, it has closed the first tranche of its private placement. The Company issued 1,250,000 common shares at $1.00 per share for total gross proceeds of $1,250,000.

Company Information

Company

X Phyto Therapeutics

Location

Vancouver, Washington, United States

About

XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.